- $6.05bn
- $5.19bn
- $147.17m
Illumina to take $1.47 bln goodwill impairment charge related to Grail in Q2 (updated)
Illumina to take $1.47 billion impairment charge related to Grail in Q2
U.S. STOCKS ON THE MOVE-Credo Technology, Eli Lilly, Gogoro
U.S. STOCKS ON THE MOVE-Norfolk Southern, Carnival, Grail
Grail slips in Nasdaq debut after spin-off from Illumina
Grail's shares fall in Nasdaq debut after spin-off from Illumina (updated)
Cancer test maker Grail starts trading after spin-off from Illumina
Brief: Grail In Connection With Separation, Illumina Made One-Time Disposal Funding Payment To Co Of About $932.30 Million
Grail bets big on flagship cancer test after spin-off from Illumina
Brief: Grail To Begin Trading On The Nasdaq Stock Exchange